Skip to main content

MoneyWorks4Me

iSERA Lifesciences Ltd (534920)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 534920 NSE: IT - Software | Small Cap | iSERA Lifesciences Share Price

₹143.90 0.00 (0.00%)

As on 17-Nov'26 15:10

iSERA Lifesciences Ltd (534920)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 534920 NSE: IT - Software | Small Cap | iSERA Lifesciences Share Price

₹143.90 0.00 (0.00%)

As on 17-Nov'26 15:10

Key Metrics
Valuation Multiples
Market Cap
₹354 Cr.
Current Price
₹143.9
52-Week Low / High
₹9 / 151
TTM EPS
₹-0.1
TTM Sales
₹1.4 Cr.
Book Value per Share
₹34.9
P/E Ratio
0.00
Industry PE
21.6
Price to Book (P/B)
4.13
Higher than its 5-year historical median
Price to Sales (P/S)
261.16
EV/EBITDA
-3104.56
Lower than its 5-year historical median
Dividend Yield
0%
Profitability Efficiency
Return on Equity (ROE)
6.37%
Outperforms industry median
Return on Capital Employed (ROCE)
5.89%
Underperforms industry median
Return on Assets (ROA)
4.28%
Outperforms industry median
Operating Profit Margin
19.6%
Outperforms industry median
Net Profit Margin
19.14%
Outperforms industry median
Gross Profit Margin
24.8%
Outperforms industry median
Growth Momentum
1-yr vs 3-yr growth
Sales Growth (1 Year)
-
403.7%
Operating Profit Growth (1 Year)
-
92.86%
Net Profit Growth (1 Year)
-
116.67%
Asset Quality
Promoter Holding
58.63%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
₹61 Cr.
Equity
₹24.6 Cr.
Face Value
₹10
All Time Low / High
₹0.53 / 152.00

iSERA Lifesciences stock performance

Key Ratios
mw4me loader

Check Before You Invest

Quality

Locked
Login to view analysis.

Valuation

Locked
Login to view analysis.

Price Trend

Locked
Login to view analysis.
Q.1 Is iSERA Lifesciences Ltd a good quality company?
iSERA Lifesciences Ltd is a weak quality company, based on a inconsistent multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

We have analysed the performance of the company on the following:

  • How has it performed on generating Profits?

    By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.

  • How efficiently has it utilized Capital?

    By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.

  • How is it managing its Debt?

    By checking its Debt to Equity and Cash Flow from Operations.

How does iSERA Lifesciences Ltd performance compare with that of its Peers?
Q.1 Revenue growth of iSERA Lifesciences Ltd vs industry peers?
iSERA Lifesciences Ltd revenue CAGR is 0.00%, compared to the industry median CAGR of 0%, indicating stable growth and maintaining its market share.
Q.1 Promoter shareholding and pledge status of iSERA Lifesciences Ltd?
Promoters hold 58.63% of the iSERA Lifesciences Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Q.1 Stock return of iSERA Lifesciences Ltd over the last decade?
Over the last 9 year(s), the stock has delivered a CAGR of 47.2% based on the current price.

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
iSERA Lifesciences Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation ⓘ

Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25Mar'26TTM
ROCE % ⓘ3.5%4.1%2.9%-2.4%-4.6%-11.1%-5,149.5%0%18.8%5.9%-
Value Creation
Index ⓘ
-0.8-0.7-0.8-1.2NA-1.8NANA0.3-0.6-

Growth Parameters ⓘ

Sales ⓘ21.428.912.32.100000.31.41
Sales YoY Gr.-35.4%-57.5%-82.7%-100%NANANANA403.7%-
Adj EPS ⓘ00.1-0-0.5-0.30-4.7-3.94.60.3-0.1
YoY Gr.-400%-140%NANANANANANA-93.3%-
BVPS (₹) ⓘ0.60.70.60.1-0.10-4.9-8.5-3.89.834.9
Adj Net
Profit ⓘ
00-0-0.4-0.3-0.1-0.1-0.10.10.3-0
Cash Flow from Ops. ⓘ-0.6-0.50.314.5-0.3-0.1-0.1-1.4-5.4-
Debt/CF from Ops. ⓘ-10.9-14.621.96.80.50-1-3-1.2-0.3-

CAGR ⓘ

9 Years 5 Years 3 Years 1 Years
Sales ⓘ-26.4%NANA403.7%
Adj EPS ⓘ46.5%NANA-93.3%
BVPSⓘ36.2%NANANA
Share Price 46.6% 176.5% 332.4% 1445.7%

Key Financial Parameters ⓘ

Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25Mar'26TTM
Return on
Equity % ⓘ
17.3-2.9-130-8044.1190.9185.159.7-75.46.4-0.4
Op. Profit
Mgn % ⓘ
2.11.62.6-2.5000052.419.721.4
Net Profit
Mgn % ⓘ
00.1-0.1-19.6000044.519.1-14.5
Debt to
Equity ⓘ
13.513.714.258.4-190-1.1-0.9-16.40.20
Working Cap
Days ⓘ
1981784041,82000001,0921,24384
Cash Conv.
Cycle ⓘ
-938-5,645-10,718-4,3910000-1613871

Valuation of iSERA Lifesciences - Standalone

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Analyst's Notes

data not found
No data found!

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.00100.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Financials

PARTICULARSMar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25Mar'26
Sales2129122000001
Operating Expenses > ⓘ + 2128122000001
Manufacturing Costs0000000000
Material Costs0000000000
Employee Cost 1000000000
Other Costs > ⓘ 2028122000001
Operating Profit > ⓘ 000-0-0-0-0-000
Operating Profit Margin (%) 2.1%1.6%2.6%-2.5%----52.4%19.6%
Other Income > ⓘ + 0000000000
Exceptional Items > ⓘ 0000000000
Interest > ⓘ 0000000000
Depreciation > ⓘ 0000000000
Profit Before Tax > ⓘ 000-0-0-0-0-000
Tax > ⓘ 0000000000
Profit After Tax 00-0-0-0-0-0-000
PAT Margin (%) 0.0%0.1%-0.1%-19.6%----44.5%19.1%
Adjusted EPS (₹)0.00.1-0.0-0.5-0.30.0-4.7-3.94.60.3
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%
PARTICULARSMar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25Mar'26

Equity and Liabilities

Shareholders Fund + 1110-0-0-0-0-08
Share Capital ⓘ 10.6010.6010.6010.6010.6000.300.320.328.41
Reserves ⓘ -10-10-10-10-11-0-0-1-0-0
Debt +7787200022
Long Term Debt5667200022
Short Term Debt2220000000
Minority Interest0000000000
Trade Payables3633200000
Others Liabilities ⓘ 2211100000
Total Liabilities ⓘ 131612104000211

Fixed Assets

Net Fixed Assets ⓘ +0011000000
Gross Block1122220000
Accumulated Depreciation1111120000
CWIP ⓘ 0000000000
Investments ⓘ 0000000000
Inventories0000000000
Trade Receivables1014109300001
Cash Equivalents flag ⓘ 0000000003
Others Assets ⓘ 2211100016
Total Assets ⓘ 131612104000211
PARTICULARSMar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25Mar'26
Cash Flow From Operating Activity ⓘ + -1-1014-0-0-0-1-5
PBT ⓘ 000-0-0-0-0-000
Adjustment ⓘ 000000000-0
Changes in Working Capital ⓘ -1-1015-0-00-2-6
Tax Paid ⓘ 0-0-0-0-0000-0-0
Cash Flow From Investing Activity ⓘ + -0-0-00000000
Capex -0-0-00000000
Net Investments 0000000000
Others ⓘ 0000000000
Cash Flow From Financing Activity ⓘ + 110-1-500018
Net Proceeds from Shares ⓘ 0000000008
Net Proceeds from Borrowing ⓘ -0000000010
Interest Paid ⓘ 0000000000
Dividend Paid ⓘ 0000000000
Others ⓘ 110-1-500000
Net Cash Flow ⓘ -0-000-000-003
PARTICULARSMar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25Mar'26
Ratios
ROE (%)0.977.27-2.91N/AN/AN/AN/AN/AN/A6.37
ROCE (%)3.454.072.94N/AN/AN/AN/AN/AN/A5.89
Asset Turnover Ratio1.771.990.870.1900000.330.22
PAT to CFO Conversion(x)N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Working Capital Days
Receivable Days160.60153.503581,591.400000430.70204
Inventory Days0000000000
Payable Days0000000000

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Annual reports

No annual reports available.

Concalls

No concalls available.

iSERA Lifesciences Ltd FAQs

The current trading price of iSERA Lifesciences on 17-Nov-2026 15:10 is ₹143.9.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 16-Nov-2026 the market cap of iSERA Lifesciences stood at ₹353.9 Cr

The latest P/E ratio of iSERA Lifesciences as of 16-Nov-2026 is 0.00.

The latest P/B ratio of iSERA Lifesciences as of 16-Nov-2026 is 4.13.

The 52-week high of iSERA Lifesciences is ₹151.1 and the 52-week low is ₹9.31.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of iSERA Lifesciences is ₹1.36 ( Cr.) .

Past 10 year’s financial track record analysis by Moneyworks4me indicates that iSERA Lifesciences Ltd is a below average quality company.

The key valuation ratios of iSERA Lifesciences Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of iSERA Lifesciences Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

About iSERA Lifesciences Ltd

No data to display
To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now